Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Bualuang Securities Public Company Limited
$23.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Bronstein, Gewirtz & Grossman, LLC Announces Law Suit Against Accretive Health Inc


Tuesday, 21 May 2013 04:05pm EDT 

Bronstein, Gewirtz & Grossman, LLC announced that they have until July 19, 2013 to file lead plaintiff applications in a securities class action lawsuit against Accretive Health, Inc., if they purchased the Company's securities during the period between May 20, 2010 and February 26, 2013, inclusive (the "Class Period"). This action is pending in the United States District Court for the Northern District of Illinois. The Complaint charges Accretive and other defendants with violations of the Federal Securities Laws. The complaint alleges that throughout the class period defendants failed to disclose the following: (i) that the Company had improperly recognized revenue under certain managed service contracts; (ii) that the Company's financial statements were not prepared in accordance with Generally Accepted Accounting Principles; (iii) that the Company lacked adequate internal and financial controls; and (iv) that, as a result of the foregoing, the Company's financial statements were materially false and misleading at all relevant times. 

Company Quote

16.4
-0.1 -0.61%
5:39am EDT